Gkardia Medical Devices

Gkardia Medical Devices is a clinical-stage medical technology company specializing in the development of advanced ultrasound-based systems for the treatment of cardiovascular and metabolic diseases. The company's flagship product is a proprietary ultrasound renal denervation (uRDN) catheter designed to treat resistant hypertension by selectively disrupting sympathetic nerve activity. Unlike traditional radiofrequency ablation, Gkardia's technology utilizes targeted ultrasound energy to achieve circumferential nerve block with minimal contact with the arterial wall, potentially reducing the risk of vascular injury. The company is currently focused on clinical validation of its platform to address significant unmet needs in the management of uncontrolled blood pressure and heart failure.